The UGDH knockdown strategies have been proposed to evaluate the role of a potential modulator of breast cancer behavior [52], considering that this reduces the intracellular UDP-GlcUA availability and therefore modulation of ECM composition at PGs and GAGs levels, which are implicated in tumor progression. The gene discussed is UGDH; the disease is breast carcinoma.